Drug & medication recalls Moderate risk

EEMT 1 recalled over manufacturing violations

Recall date
April 17, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Syntho Pharmaceuticals, Inc. recalls EEMT (esterified estrogens and methyltestosterone) 1.25 mg/2.5 mg, tablets,100-count bottle, Rx only, Manufactured By:…
Recall number
D-0378-2019
FDA classification
Class II
Brand / firm
Syntho Pharmaceuticals, Inc.
Sold / distributed
Product was sold to the firm's sole distributor who further distributed the product throughout the United States.

Why it was recalled

CGMP deviations: Lots were recalled due to sub-potency and cGMP violations.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

EEMT (esterified estrogens and methyltestosterone) 1.25 mg/2.5 mg, tablets,100-count bottle, Rx only, Manufactured By: Syntho Pharmaceuticals, Inc., Farmingdale, NY 11735, Distributed By: Creekwood Pharmaceutical, Inc., Birmingham, AL 35242, NDC 15310-010-01

Get recall alerts

Free email alert whenever Syntho Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Syntho Pharmaceuticals, Inc.